Injectable codeine is available for subcutaneous or intramuscular injection only; intravenous injection is contraindicated, as this may lead to nonimmune mast-mobile degranulation and ensuing anaphylactoid response. Codeine suppositories also are marketed in a few nations. In Eire, new laws arrived into effect on one August 2010[ninety] regarding codeine, on account https://www.codeingil.com/